We observed an individual effect of NCGC607 treatment on GCase activity restoration for each patient, ( Supplementary Figure S2a ), but the differences did not reach statistical significance ( p > 0.05).
← all excerpts
Potential Binding Sites of Pharmacological Chaperone NCGC00241607 on Mutant β-Glucocerebrosidase and Its Efficacy on Patient-Derived Cell Cultures in Gaucher and Parkinson's Disease.
1
0.0500
0.0500